Results 11 to 20 of about 23,298 (210)

Real‐World Experience with a Human Fibrinogen Concentrate: Clinical Data from Adult and Pediatric Patients Requiring Fibrinogen for Bleeding Control and Prevention

open access: yesThe Journal of Clinical Pharmacology, Volume 63, Issue 11, Page 1186-1196, November 2023., 2023
Abstract Human fibrinogen concentrate (Fibryga) received temporary approval for fibrinogen replacement therapy in France (2017), with subsequent full approval for congenital and acquired hypofibrinogenemia. We evaluated real‐world use for on‐demand treatment of bleeding and prophylaxis to enhance our knowledge on fibrinogen concentrate as an option for
Francois Stéphan   +8 more
wiley   +1 more source

Decompressive surgery in cerebral venous sinus thrombosis due to vaccine‐induced immune thrombotic thrombocytopenia

open access: yesEuropean Journal of Neurology, Volume 30, Issue 5, Page 1335-1345, May 2023., 2023
Abstract Background and purpose Cerebral venous sinus thrombosis due to vaccine‐induced immune thrombotic thrombocytopenia (CVST‐VITT) is an adverse drug reaction occurring after severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) vaccination.
Katarzyna Krzywicka   +52 more
wiley   +1 more source

Neurological symptoms and complications in predominantly hospitalized COVID‐19 patients: Results of the European multinational Lean European Open Survey on SARS‐Infected Patients (LEOSS)

open access: yesEuropean Journal of Neurology, Volume 28, Issue 12, Page 3925-3937, December 2021., 2021
We retrospectively analyzed data from 6537 predominantly hospitalized COVID‐19 patients registered in the European multinational Lean European Open Survey on SARS‐Infected Patients (LEOSS) registry between January 2020 and February 2021. Common neurological symptoms were excessive tiredness (28.0%), headache (18.5%), nausea/emesis (16.6%), muscular ...
Nina N. Kleineberg   +31 more
wiley   +1 more source

Umbilical cord mesenchymal stem cells for COVID‐19 acute respiratory distress syndrome: A double‐blind, phase 1/2a, randomized controlled trial

open access: yesSTEM CELLS Translational Medicine, Volume 10, Issue 5, Page 660-673, May 2021., 2021
Abstract Acute respiratory distress syndrome (ARDS) in COVID‐19 is associated with high mortality. Mesenchymal stem cells are known to exert immunomodulatory and anti‐inflammatory effects and could yield beneficial effects in COVID‐19 ARDS. The objective of this study was to determine safety and explore efficacy of umbilical cord mesenchymal stem cell (
Giacomo Lanzoni   +30 more
wiley   +1 more source

Recovery from Liver Failure and Fibrosis in a Rat Portacaval Anastomosis Model after Neurointermediate Pituitary Lobectomy

open access: yesJournal of Immunology Research, Volume 2021, Issue 1, 2021., 2021
Liver diseases, including cirrhosis, viral hepatitis, and hepatocellular carcinoma, account for approximately two million annual deaths worldwide. They place a huge burden on the global healthcare systems, compelling researchers to find effective treatment for liver fibrosis‐cirrhosis.
Martín Muñoz-Ortega   +8 more
wiley   +1 more source

Evaluación de la tromboprofilaxis en los pacientes ingresados en el Hospital San Juan de Dios, abril a junio 2012

open access: yesRevista Clínica de la Escuela de Medicina UCR-HSJD, 2012
Antecedentes: La trombosis venosa y el tromboembolismo venoso son complicaciones frecuentes en los pacientes durante su hospitalización, inclusive posterior a su egreso hospitalario.
Allan Robles Calderón   +1 more
doaj   +1 more source

Hemodiálisis extendida frente a convencional o hemodiafiltración en línea. Estudio comparativo de necesidad de heparina y coagulación del sistema

open access: yesEnfermería Nefrológica, 2021
Introducción: La reciente aparición de membranas de corte medio ofrece una alternativa para la eliminación de moléculas medianas y nueva terapia dialítica, la hemodiálisis expandida. Estas membranas se caracterizan por un mayor tamaño de poro que podría
Raquel Pelayo-Alonso   +4 more
doaj   +1 more source

TROMBOCITOPENIA INDUZIDA POR HEPARINA COMO CAUSA DE TROMBOEMBOLISMO PULMONAR: RELATO DE CASO

open access: yesHematology, Transfusion and Cell Therapy, 2021
Objetivo: Relatar e discutir as abordagens diagnóstica e terapêutica de um caso de tromboembolismo pulmonar (TEP) por trombocitopenia induzida por heparina (HIT).
VG Freitas   +9 more
doaj   +1 more source

MODELO EXPERIMENTAL PARA O ESTUDO DA INTERAÇÃO ENTRE METABOLISMO DA GLICOSE E DOS ÁCIDOS GRAXOS LIVRES NO EXERCÍCIO EM CONDIÇÃO DE HIPERLIPEMIA

open access: yesRevista Brasileira de Atividade Física e Saúde, 2012
Este estudo foi delineado para desenvolver um modelo animal de hiperlipemia crônica, independente de manipulação dietética, vi­sando análise da interação metabólica glicose/ácidos graxos livres (AGL) no exercício.
Maria Alice Rostom de Mello   +2 more
doaj   +1 more source

Home - About - Disclaimer - Privacy